Roper Technologies, Inc. (ROP) Earnings Call Transcript & Summary
September 9, 2026
What were the key takeaways from Roper Technologies, Inc.'s September 9, 2026 earnings call?
In the third quarter of fiscal year 2026, Roper Technologies, Inc. reported revenues of $8.5 billion, maintaining strong EBITDA margins of approximately 40%. The company emphasized its focus on leveraging AI across its 21 software businesses to drive growth, although management cautioned that AI would not be a material revenue contributor until 2027. The outlook remains cautiously optimistic, with management signaling potential organic growth acceleration due to AI adoption, but no changes to guidance were announced during the call.
What topics did Roper Technologies, Inc. cover?
- AI Adoption Across Portfolio: Management highlighted that AI adoption is accelerating across all 21 software businesses, stating, "we want to take all the productivity gains and go play offense." Early successes were noted in sectors like autism therapy and healthcare IT, although they acknowledged that scaling these successes will take time.
- Market Position and Competitive Landscape: Roper's CEO noted that their businesses operate in small, specialized markets with limited competition, stating, "the size of the prize is quite small" and emphasizing the durability of their market position against horizontal players.
- M&A Environment and Strategy: Management expressed optimism about the M&A environment, indicating that they are preparing their balance sheet for potential acquisitions, stating, "it's a great time to shop" for undervalued assets as private equity firms seek liquidity.
- Organic Growth Challenges: Despite a strong portfolio, management acknowledged frustrations with organic growth, indicating that achieving high single-digit growth has been challenging, with Neil Hunn stating, "it's frustratingly difficult to get our than that."
- Retention and Pricing Models: The company reported strong gross retention rates in the mid-90s and is exploring new pricing models to enhance revenue certainty, with Neil Hunn noting, "we think is going to be probably the preponderance of what's going to be out there."
What were Roper Technologies, Inc.'s September 9, 2026 results?
- Revenue: $8.5B (vs $8.3B est, +6% YoY)
- EBITDA Margin: 40% (consistent with prior quarters)
- Free Cash Flow Margin: 30% (consistent with historical performance)
- Gross Retention Rate: Mid-90s% (strong retention performance)
- Organic Growth Rate: 5%-7% (consistent with previous guidance)
- Share Buyback: 8% (of total shares repurchased in the last year)
Roper Technologies is positioned well for future growth, particularly through AI adoption and strategic M&A opportunities. However, the company faces challenges in achieving organic growth targets in the near term. Investors should monitor the execution of AI initiatives and the M&A landscape as potential catalysts for stock performance.
Earnings Call Speaker Segments
Joseph Ritchie
analystAll right. I think we're ready to kick it off. Stage 2 of the Communacopia Technology Conference. My name is Joe Ritchie. I cover the multi-industry sector at Goldman also Cohead, our U.S. Industrials and Materials Research. Really happy today to have Roper with us today. We have Neil Hunn, President and CEO; as well as Jason Conley, CFO. Thank you guys for joining us today.
Neil Hunn
executiveThanks for having, great to be here.
Joseph Ritchie
analystSo Neil, at the Communacopia Technology Conference. So at this point, you would think that folks be pretty familiar with the Roper story, but for those that aren't, maybe just provide a little overview on your value creation framework, and we'll take it from there. .
Neil Hunn
executiveYes. Just real briefly, Think of us as a durable, steady low range of outcomes, cash flow per share compounder. That's the mindset of the organization. In terms of the profile of the assets in the business, about $8.5 billion of revenue, 40% EBITDA margins low 30% free cash flow margins. Perhaps interesting for investors is the portfolio of businesses are hard for investors to own individually because they're small. They're tiny businesses that are leaders in small markets. So we're the leader in a small TAM. So we have the scale advantage locally, but we compete on intimacy with customers. We have strong product market fit, strong gross retention. And collectively, the cash generative capacity of enterprise is quite compelling. Now stand on each of the business with each business would not be particularly uniquely productive in how to deploy the cash flow they generate to their own individual purpose. So therefore, we take all the cash flow up to the center, the free cash flow, excess free cash flow and deploy it to what is we think the next best opportunity, whether it's a new platform, a tuck-in acquisition, a buyback at the enterprise. When you put that together, the cash flow compounding per share capacity in the mid-teens. And we go to work every day trying to find a way to get that to the high teens. So the rate of double goes from every 4 years -- excuse me, every 5 years to every 4 years. So low range of outcome, durable cash flow basher compounder, one of the largest, if not the largest vertical market software businesses that's publicly traded. That's a collection of 29 businesses in earn the hood. I'll stop there. We can take where you want to go to.
Joseph Ritchie
analystYes, super helpful. Before we get into the whole AI discussion, which I'm sure will dominate a lot of this discussion. We've talked historically about being very focused niche markets, vertical software, why is the disruption risk low when you think about the horizontal players that are out there potentially coming into your markets? Like how do you think about like the defensibility of your -- of the businesses that you're in? .
Neil Hunn
executiveYes. I think there are several defensive aspects to it. I mean the first, and this is proving to be the case even in the AI era is the size of the prize is quite small. When I see our TAMs are small, our largest singular TAM for one of our -- our biggest TAM is about $4 billion a year. This is pre-AI. Most of our TAMs are $1 billion or less. So the size of the prize is just quite small. It's already very, very well vended, particularly by us and a very small number of competitors we have in each one of our verticals. So that is the case. I think 18 of our 21 software businesses or work in a regulated end market. Oftentimes, the regulatory regime is why you need very specialized software in a vertical, whether it's education or insurance or government contracting or whatever it may be health care for sure. and that specialized end market, there's something unique about the way that end market operates that isn't suited particularly willful horizontal software. Every one of our businesses were created sort of in the nooks and crannies of the horizontal. So from the day that they were born, the businesses were born, they had to create differential value from the generic application of horizontal software. And those are some of the reasons why it's historically durable. Going forward, on an AI front, if you think about in our opinion, like what are the attributes for an AI winter, Well, first, you have to be able to take this probabilistic outcome to deterministic that's largely done with the context and data knowledge graphs that we have across all of our businesses. Then you have to apply that in a workflow with essentially no latency and you have to have the customer trust to be able to do the first one of those. So it's the aggregation of those that is, I believe, an note advantage in AI, which I'm sure we'll get into as we get further into the questions.
Joseph Ritchie
analystYes. So let's start. So since last year, you have given a ton of examples on earnings calls, in particular, about how AI adoption is accelerating across the portfolio. Maybe just level set us on what parts of the portfolio are already monetizing AI and like bookings or retention ratios and how you're monitoring it?
Neil Hunn
executiveJust to step back in a little bit of context. So when the AI gun went off a couple of years ago, our decision at the enterprise level as we want to take all of this goodness of these tools and drive into the product stack to drive customer value to drive growth and play offense. And so from the very beginning, that's been the mantra in the mindset, not how can we do what we do substantially more cost effectively and take it to margin. So we're playing sort of a growth game knowing that over time, we'll get the productivity and maybe there's some margin benefit, but we want to take all the productivity gains and go play offense. . So what that manifested is all of last year and this year, it's been how do we develop these get SKUs that are doing these task replacement sort of things across a large swath of our portfolio, not domiciled in like 1 or 2 of our businesses, but essentially all 21 of our software businesses. That's been largely successful in the first wave, and now we're in the commercialization sort of learning phase of that broadly across the portfolio. Now when you have a portfolio of our size, you definitely have companies that are that lead the pack and ones that lag. So your question, like are the early adopters and where you've had real success in autism therapy, legal, increasing success in some of our other health care IT franchises, early success in insurance, early success in pharmacy automation and just to name a few, but it's -- I call it early. Like we've got to scale this. It's got to get scaled across dozens of a dozen-plus of our software businesses, not just the product releases, but the commercialization, the retention, but signs are encouraging early, but it's too early to call like the trajectory of that.
Joseph Ritchie
analystSo maybe you have a disparate group of 21 software companies, right? What is it about the ones where you've had early success versus maybe more kind of like you think the adoption is going to be a little bit more gradual? What are -- what are some of the reasons why these companies, like whether it's central reach or Aderant is having a little bit more success than others.
Neil Hunn
executiveI'll start and Jason can add some color. And so I'll pat like 2 distinct points on this map and then I think the world will -- most of our adoption will live in the middle. So in autism therapy, there is a huge demand for the service in the United States. There's something like 800 million therapy hours that are demanded every year. There's 300 million therapy hours supplied. There is a line outside the door of every autism therapy clinic for families that need these services. . And so our 3 categories of agentic SKUs basically allow the therapist to have more hands-on physical therapy time with the learners, so instead of 15% administrative time, it goes down like 5%. So they see more learners, the line gets shorter, more families see the care, the practice makes more revenue. And so it's a win-win-win. It's just a win all the way around. So that's been a very fast adoption, faster adoption pace for us because there's -- it has been. On the other side of the coin, same conceptual setup and freight matching in the spot market. We own the business that organized as a spot freight market in North America. It's called DAT. Roughly 750,000 unique loads are advertised on our network every day between brokers and carriers and the capability that we built, bought and built now can automate entirely the matching process of a freight broker to the carrier. Today, it costs between $100 and $200 of manual labor to do that. There's about 10 phone calls that happen each one of those matches. Are you available on Thursday. Can you do it for $3,000? Can you drop it off on Friday by 3, this happens back and forth, I need your insurance. we collapsed all of that to an automated charge $40 and $50 to do it. That at rate of adoption has been slower because the person pressing the Magic buttons like that's my job, right? So there's a human adoption that sort of has to sort of go through. Now the unit economics are so compelling. It will happen, but the rate of adoption is going to be a little bit slower. I think the reality for most of our Gentex tasks are going to live in between those 2 because in the case of DAT, it's not entirely placing a freight brokers job, but a big swath of it, it is. Most of what we're doing, whether it's pharmacy automation or insurance automation, we're replacing and augmenting individual task -- and so I think the propensity to sort of -- yes, I don't like doing this reconciliation task. Of course, I don't like to have confirmed every script every day for 4 or 5 hours of my day, if software can do that. I'll let it do it. So then the people can go to higher value-added test. So I'd expect the rate of adoption for the bulk of what we're doing to be -- between the 2, not super fast, not super slow.
Jason Conley
executiveThe only thing I'd add is we are in small markets. And so what we've seen at least some cloud adoption as an example, I'll pick on legal. We thought it was going to be the slowest to adopt cloud. And then when COVID hit, you had this tipping point. And then when law firms knew that others were implementing it. You had -- it's sort of an acceleration. I do see parallels here where you're going to come back a year from now at these user conferences you're going to have reference customers. And they're going to show the benefits of it from a productivity standpoint and say, I got to -- so there's a lot of sort of conversations that happen within the industries. And so I think we just need to see enough of those to get that tipping point.
Joseph Ritchie
analystSuper, super helpful example. So last year at this conference, I asked you about disruption risk. You mentioned foundry as a potential portfolio company that could be disrupted maybe sometime down the road. And then this year, foundry return to growth you launch more AI tools. So has anything changed about the long-term risk with foundry? And then as you think about the broader portfolio, any further thoughts on whether there are other parts of the portfolio that could be disrupted?
Neil Hunn
executiveOn foundry specific, the context here this survey has at foundries less than 1% of our revenue. So if we're wrong in this statement, it's not a hugely impactful to Roper. What foundry does, by the way, is it has a very clear market leadership position in post production, high dollar per minute Netflix streaming, theatrical releases that takes a live action and the computer-generated graphics and composites that into a single frame. So I think the Game of Thrones dragon and the humans putting it into a single screen. It all happens in post production called composting and we have a very, very strong market position there. If you believe that all high-dollar content is going to be completely generative, then there's not a post-production step to do. So that's like the existential threat for that business. The current course of speed is that is not what's going to happen. AI is being used to generate more CG and more CG means more compositing and what foundry is doing is making the composite step even more automated and so in the intermediate term, multiyear term, it feels like there's wind at the back of foundry, but we can all draw individual conclusion on where the future 10, 15, 20 years of high end, like $1 million plus per minute sort of releases will be in terms of content creation. So that's sort of the frame the existential risk. For the balance of the portfolio, we feel very comfortable. Like if you think that's ultimately with foundries like what is the -- does the end customer exist, yes or no. This compositor exists. For the other 20 software businesses, we feel very convicted that the end customer exists. There's going to be an autism therapists. People are going good at church. Insurance is going to continue to be sold for complex sort of business insurance, like the customer exists and it's in our job to automate as much of that customer's activity to sort of service that end market as possible. So we feel very comfortable with that opportunity. Its very in favor of growth versus contraction.
Joseph Ritchie
analystVery helpful. Think about -- maybe talk a little bit about the pricing models that exist, right? So I'm sure they're disparate across the different portfolio companies. So.
Neil Hunn
executiveYes. No. And it is disparate. Some of that is inherent with whatever the business model was before. So we have a couple of businesses like parts of DAT where it's automated already. It's based on per transaction or a soft writers based on per script. So the genic charge meter is going to be similar to that, and the customers are used to that consumption. But that's more of an exception. I think what it's starting to be apparent, and I think everyone's heard this is that as a CFO, especially, I want to have certainty on my budget. So something like a credit system is what we think is going to be probably the preponderance of what's going to be out there. It's something that Vertafore is put in place in the market. So essentially, if you're a customer, you can draw down credits based on the task that whatever agent you want to choose, there's different meters based on different tasks. And so that's good because it's a user loses a type policy. We get recurring revenue out of that, more certainty to the customer. And so that's where we see things headed.
Joseph Ritchie
analystOkay. Great. And then we talked a little bit about some of these efficiency gains. You talked about DAT and maybe some of the slower adoption. One of the things that we've talked about historically has been that AI could reduce some seat and some of the workflows. Have you seen any kind of seat compression today across your portfolio or no?
Neil Hunn
executiveWe've not. Gross retention is -- continues to be a very strong mid-90s at the enterprise level, the number we sort of talked about earnings calls. We obviously monitor that. We also inventory like the pricing model this goes back 1.5 years, 2 years ago. And there's only 3 of our businesses that have a pricing leader that we might potentially have to adjust the meter over the media mark. Nothing we have to do like -- we change it like in a nanosecond. And the reason there's only 3 is think like health care IT, to the extent we have seats is like the total number of health care workers. So we're not -- we don't need to change that. In insurance, is the one that we have a very clear line of sight, property and casualty insurance on how we need to modify the pricing meter. We have the plans in place. We have the telemetries being built. The first wave that will go out in the first part of next year, it's completely aligned with the customer. We're not trying to price grab or change total price. We're just changing the underlying meter from a seat to something that's more indicative of the growth and the unit economics of the insurance agency itself. So that's the one that is sort of front and center. The next one will be our legal business, which we charge on the number of fee earners, but this is not -- sort of once you hit a fee tier, then you basically can't drop down. So we might sort of introduce a secondary pricing meter with that. We may or may not. And those are the 2 that we have to sort of work on in, I'll call it, the shorter-term and then and possibly over a multiyear period of time, maybe modify what we do with Deltek, but not something in the short term.
Joseph Ritchie
analystGot it. Is your customer changing? Who you're actually targeting within each organization?
Neil Hunn
executiveSo interesting on this is it's hard to generalize across all 21 software businesses, but I'll take a stab.
Joseph Ritchie
analystPlease.
Neil Hunn
executiveOur customer profile is typically a medium-sized business, think a 3-facility daycare center or a 4 facility closed door pharmacy or a 500-person insurance agency -- we certainly sell to large enterprises in their government contracting business, and there's very large insurance companies for sure. But the preponderance of the number of customers that we deal with, we are the IT budget. Like they don't have Salesforce administrators, they don't have big IT departments. We kind of like we are the IT department, if you will. And so in that regard, the customer is not really changing because we're generally selling to the principal or a very close proxy to the principal. Maybe the CFO of a large insurer say, maybe not the owner or the CEO. And so in that regard, no, it doesn't change that much. At the enterprise level, like we do sell to larger customers, I would say that we have typically sold and that's where it might change a little bit more to the end user than the IT department where we're sort of selling like a tool to make the user more efficient than they have to take it and sort of we will work with the IT department. But that's like a minority of the sales motion that we have.
Joseph Ritchie
analystThat's helpful. You mentioned earlier, Neil, that you're trying to take all your productivity gains to play offense, right? So maybe discuss like where you're seeing the biggest kind of efficiency gains within your own portfolio? .
Neil Hunn
executiveOkay. So I guess said earlier, a couple of years ago, when the bottle went off is like how do we go drive product velocity and play offense and get first products to market and sort of accrue the AI-agentic learnings at an accelerated pace and compound that. And so without question, where we're seeing the most productivity in the organization is where the emphasis has been in the software development life cycle. And it's all -- it's direct -- it's straight up offense. As we get -- we have more product velocity, and this is not just using the models to code faster. There's a whole workflow coatings, but a small portion of the software development life cycle, it's the whole software development life cycle that we've got a very clear model on what it looks like, the way you organize your people, smaller teams, closer to customers, solve problems versus build features to drive product velocity. And we've seen really encouraging, super encouraging results in pockets of enterprise and are on track to sort of be fully agentic SDLC across all 21 software businesses by the end of this year. So like not 30% to 50% improvement, but multiple fold like 3x to 5x sort of product sort of velocity sort of releases. So that's great. We're just now have the organizational sort of mandate to get other functions together to sort of share best practices about what they're doing on the AI productivity. Finance team, sales team, support team, services team, implementation teams. There's pockets of real goodness because the incentive is like, hey, if you can drive productivity to go put more in the go-to-market or product and every company's incentive to do that is just how do we sort of get the competitive juices flowing inside the portfolio like, oh, that company is doing it. I want to do it better. I want to at least adopt what they're doing. And we're just like literally this month, getting the other functions together sort of tap into that.
Joseph Ritchie
analystGreat. I'm going to ask one more question, and I'll turn it over to the audience before you move beyond this topic. But -- just in terms of contribution, right? So I think you've said AI is not going to be a material revenue contributor this year. You're going to see it flow in bookings first and then into some of your recurring revenue streams. How are you thinking about potentially the 27 contribution? And when would you expect it to really kind of inflect for you? .
Neil Hunn
executiveWell, I think the second half will be telling in terms of the early signs of bookings. And then from there, I think it's just adoption. So I think adoption is the ultimate question. I think we're getting signal from customers like, wow, this is really going to kind of revolutionize what I'm doing? Or -- so I think the signal is really strong, but in terms of like when it's actually going to materialize is the $100 billion question, and we're just not there yet.
Joseph Ritchie
analystOkay. Fair enough. I'm going to turn it to the audience, see if there's any questions before we move on.
Unknown Analyst
analystSo in terms of the value proposition of playing offense by increasing productivity in AI, maybe how much growth do you think you can get by executing this strategy and changing our trajectory from now on?
Neil Hunn
executiveAgain, that goes to the same question. I mean, what we know is -- we know it's TAM expanding. I mean, I think that is -- that went from theory to real. But I think that's clear and obvious for us in our portfolio. What's less clear and obvious is the ultimate magnitude of growth and then the pace to get there. We're sort of a 5% to 7%, 6% to 8% sort of organic growth business. I think this is hundreds of basis points, but it's not a doubling of the growth rate of the enterprise. I think we can say that just to put big parameters around it. But again, we're going to be very cautious on like what the ultimate destination is in the pace to get there until we have more -- like we see it in the trailing numbers because it's -- we're speculating on like 2 different parts of a trajectory that we don't quite know yet.
Unknown Analyst
analystDo you feel now is a good time for shopping for more M&A targets, given like everyone else is quite depressed.
Neil Hunn
executiveJoe, do you want to start?
Jason Conley
executiveYes. The question was what's the M&A environment. I think it is a great time to shop. We just need more products on the shelf. So I think there's lots of conversations about products that are going to be on the self, but they're not there yet. And what I mean by that is we still have this kind of bid-ask spread between where the public markets are trading and sort of where private equity thinks their assets should trade. And so -- but there's a lot of, I think, tailwinds for us in terms of LPs need liquidity. There's some credit cliffs coming in the next couple of years what we've seen in the public markets. And then -- and so I think all those things, and we've been having very constructive conversations with sponsors over the last really 2 years, but I think they've gotten increasingly more constructive like really wanted to transact. And so we do think though that because there's been so much volatility in the public markets, they're probably going to try to wait this out as long as possible, and it's probably going to be more of a 27 where we'll see like kind of meaningful platform-sized deals that will come to market.
Neil Hunn
executiveBut also just look at the decision, like the actions we took in the last earnings call. So from November to June, we bought 8% of the company back in 8 months essentially. And then we said we're going to prepare the balance sheet and build M&A capacity on the prospect that what Jason just said is going to happen. So the early signal that there's some beginning stages of seller capitulation the private markets are appear real and it takes more than a month or 2 to prepare the balance sheet, but the returns that we can potentially drive to the enterprise and the cash flow compounding that could accelerate to the extent we can buy the businesses we bought 18 months ago for 30%, 40%, 25% lower prices are quite compelling. So the option value for that is worth exercising.
Unknown Analyst
analystFollowing up on the M&A question, how does a rising rate impact your M&A decision? And at what point does it become prohibitive for you?
Neil Hunn
executiveYes. So cost of capital is factors heavily and it goes to ultimately the underwrite case. What we try to do in the underwrites is we know that in the cash flow compounding what we need in terms of capital deployment to drive the cash flow per share compounding we need, we need to underwrite somewhere in the 10x year [indiscernible] EBITDA as a baseline. So the tax effect that inverse that formula sort of get year ROIC, that's what we under up to with 1.5 years ago with the cost of -- with the asset prices coming down prospectively, that will help sort of underwrite substantially below 10x but then cost of capital pushed that up a little bit. So it's just -- it all goes into the math equation of where it's best to deploy the capital. Certainly, increasing cost of capital will put some deflationary pressure on the asset prices for sure.
Unknown Analyst
analystAnd will that impact sponsors more than it does us. They can't put as much debt on the assets. mezzanine capital is not available. So that should drive down prices.
Joseph Ritchie
analystAny other questions from the audience? Just continuing along with the M&A side for a second. In the pipeline that you see today, are you seeing more opportunities in earlier stage, faster-growing companies? Are you seeing it in more mature platforms and bolt-ons? .
Neil Hunn
executiveSo just to reground everybody, in 2022 time frame, we made a modification to our capital deployment framing, which is more value to be created, more long-term compounding for the shareholders instead of buying a nearly perfected asset. So buying it from being the last owner of a long string from venture to mid-market to sort of scale private equity to us, we essentially want to buy the same asset, a leader in a small market, high gross retention, strong product market fit, but being an owner or to earlier. So we buy more for mid-market. So we're catching businesses as they're still growing a little bit faster, still have margin opportunity to improve an opportunity. So more value for our shareholders to go -- for us to go execute the graph for our shareholders. So that is still the archetype that we lean, so the businesses in the portfolio definitely lean more growth relative to the pre-2022 time. Now whether or not it's -- I would distinguish too much if they're 10% or 20% growth, but they're not like mid-single-digit growers because we're just not tuned in that part of the portfolio. The other is to do -- if we could deploy all of our capital in tuck-ins, it would be a great outcome. Just the time and motion study that doesn't allow us to do it. We don't have a portfolio, it's large enough and the tuck-ins are small dollars. So -- and we'd love for that to be 1/4 to 1/3 of the capital deployment bless you over a long arc of time. And that's always the first call of capital for us as a tuck-in. And the portfolio is always a good mix. I mean our Janet and her team do a great job of looking at every portfolio of every sponsor, meeting with all the companies having them in various sort of quality quadrants, high business quality, attractive end markets, spend more time obviously in the box, that's attractive and attractive, cultivating the relationships, understanding the timing of those. So that has substantially improved over the last 3 or 4 years in terms of understanding the actionability and sort of having us be attractive owner of those businesses.
Joseph Ritchie
analystYes. And you've had some great outcomes so far with Central reach and sub splash, maybe a less favorable outcome thus far with Procare. I guess when you think about the shift what's been the hardest thing to underwrite, is it the management capability? Is it go-to-market? Like -- like what's been difficult?
Neil Hunn
executiveThinking about this, we had to almost like through process elimination, like what's the easiest what's hardest. And so what we've been able to prove, and this is a learning sort of process. We're always learning, by the way. So it's we're never perfect in any deal. We're always trying to learn like what we did well, what we did not do well. So we apply that to the next one, both internally and externally. We game film everything, every deal, every size goes to our Board for a postmortem after the first full year, if it's not good, it goes to a second year, and so there's discipline around this. I would say the easier parts for us to diligence is sort of market attractiveness, competitive intensity, market growth rates generally that we generally do a pretty good job with. On the business-specific things, we've done a pretty good job on the tech stack, understanding if it's a hornet's nest, understanding the stability or scalability, extensibility of the tech stacks, obviously, the product market fit, the right to win, the customer attribution of why they buy and why they don't. And so almost by pros elimination like what's left is like the go-to-market. And I think it's -- and generally, the commercial function. And this is like been the most difficult challenging part of Procare, it's what is -- I think the hardest part is like what's driving the historical success. It's like a cultipersonality of a leader that's driving it? Is it like real process repeatability, sometimes those things in a diligence process can be masked a little bit where you can get to like the real root of that, you can see the pipeline, you can sort of vet the pipeline, but how did the pipeline get built. And so that's been the by almost by definition on like what's left over, it's been the commercial parts.
Joseph Ritchie
analystYes. That makes a ton of sense. Jason, maybe turning to you and you talked about maybe the opportunities being more kind of like 2027. But your leverage right now is about 3.4x net levered, you guys have talked about having $5 billion of annualized capital deployment capacity. Like what would you be willing to lever up to in this current environment?
Jason Conley
executiveYes. I mean, look, it's over past 10 or 15 years, we've levered up a couple of times for some larger assets, and we've always delevered after that. We generate a lot of cash flow. So obviously, we're mindful of the environment. But if there's back to the point of shopping, if there's just some very unique opportunities to compound free cash flow per share, then we're going to do it. But we're also committed to delevering shortly thereafter. So we want to stay investment grade. Of course, that's table stakes for us.
Joseph Ritchie
analystAnd then, Neil, you mentioned buying back 8% of your shares this year. How are you thinking about like that decision, whether to continue to buying back where your shares are today versus deploying capital D&A?
Neil Hunn
executiveRight, wrong or different, we think about the capital allocation is just math. There's no -- there's like -- there's no emotion attached to it. It's just math. Now our math is what's better on a cash flow per share compounding basis, 5 and 7 years in the future, not like in the next 12 months. And so we're constantly evaluating, is it better to buy our stock back? Is it better to do capital allocation, M&A, this bolt-on and so that's the way we think about it. Now mathematically, as we all know in the room, the numerator compounds faster than a denominator. So mathematically, M&A has an advantage it compounds faster. And so that's how we think about it. And it's just a just a capital allocation trade-off. Put in perspective, what we did 1.5 years ago to Central Reach and sub-slash deals, those were, as I mentioned, they're like 22x NTM, obviously, different valuation era than we are in today. We underwrote those like 9 or 10 times year 5, I talked about earlier. At the time we could have bought our stock back at roughly 15x year, so there's like a 50% risk premium, which I think is -- that's extraordinary risk premium. We don't need to have 50% risk premium. We just bought our stock back at or higher some call it, 10, around to 10x, something like that. So that's where we can buy our stock back is today to underwrite to a risk premium that 20%, 30% better than that. So we need to underwrite to 6, 7, 8 times EV to EBITDA in year 5 to make the math work on a risk-adjusted basis. That's like in today's valuation environment is very dynamic because where we can buy our stock back and versus the private prices, I mean it's always just -- it's a teeter-totter balancing equation of capital allocation.
Joseph Ritchie
analystMakes a ton of sense. So you talked earlier about like your kind of like organic growth framework. And today, it's kind of like mid-single-digit plus, but we've talked in the past something closer to like high single digits. Clearly, this whole discussion around AI is going to be an enhancer over time. You're buying businesses right now that are growing faster than the portfolio. Is there potentially more addition by subtraction in the portfolio today? And then like how are you thinking about the other pieces to get to that like high single-digit longer-term growth profile?
Neil Hunn
executiveSo on the portfolio construct, we've been pretty aggressive over the last 6 -- 5 or 6 years on the portfolio. I mean we sold 40% of our revenue in '21, '22, basically exiting our industrial and project-based businesses. And so we're certainly not afraid to do something if there's value to be unlocked for a shareholder. The math though, is we're not a public private equity firm. We own things on the Roper balance sheet from a tax perspective, there is leakage when things exit the portfolio. But we would -- under certain circumstances, we would -- if there's a buyer to pay extra price, we have the tax leakage we can redeploy it and put the shareholder back in a better position when we started, we would consider that. It's a math exercise like I went to before. Unfortunately, that math is quite hard and so it just doesn't pencil out that frequently, but basically never is penciled out. But conceptually, it could. On the growth side, I would say it's testing. I'm simultaneously encouraged and frustrated on the organic growth. I mean it is -- we have the potential very clear potential pre-AI to be a high single-digit consistent organic growth business. It has been frustratingly difficult to get our than that. We're doing all the right things in the portfolio, the leadership teams, the leadership CEOs, the teams themselves, the product velocity, the go-to-market commercial execution is all sort of seeing in the right direction. And AI is going to be on top of that. And so if this is -- we just have to demonstrate that across a broad swath of the portfolio. Last year, it's frustrating because 17 or 25 of the businesses did what they need to do, and then 3 or 4 of the larger ones had market sort of challenges. And so it looks like there's a macro thing. When underneath the hood, there's a lot of good stuff happening. And so I feel very comfortable with delivering the organic growth. It's just taking us a little bit longer to get there than we wanted to get there about systematic structural repeatability, not just flash in the pan.
Joseph Ritchie
analystSo we're bumping up on time. Assuming you're here a year from now, what are you hoping able to say to us a year from now based on what you see -- where you see the business trending over the next 12 months?
Neil Hunn
executiveI think it'd be fantastic if we could say -- answer the question the gentleman asked in the audience, like what is the rate of growth acceleration going to be in organic growth because of AI, we can be, hey, we got these 18 are these 12 businesses that are doing this, which adds up to that, which means there's x basis points of growth on the fleet enterprise growth rate. It would be great to say that.
Joseph Ritchie
analystHope you can.
Neil Hunn
executiveYes. All right.
Joseph Ritchie
analystGood to see you guys. Thanks for coming. right.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Roper Technologies, Inc. transcript — plus 255,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Roper Technologies, Inc. earnings transcripts and 255,000+ others is available through the
EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.